Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Caballero, J.
Right arrow Articles by Heffernan, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caballero, J.
Right arrow Articles by Heffernan, E.
American Journal of Health-System Pharmacy, Vol. 65, Issue 3, 229-233
Copyright © 2008. American Society of Health-System Pharmacists, Inc. All rights reserved. 1079-2082/04/0602-1242$06.00


Practice Report

Development and outcomes of a psychiatric pharmacy clinic for indigent patients

Joshua Caballero, Garry Souffrant and Eileen Heffernan

JOSHUA CABALLERO, PHARM.D., is Assistant Professor, College of Pharmacy, Nova Southeastern University, Ft. Lauderdale, FL. GARRY SOUFFRANT, M.D., is Medical Director and EILEEN HEFFERNAN, R.N., M.S.N., is Performance Improvement Coordinator, Su Clinica Familiar, Harlingen, TX.

Address correspondence to Dr. Caballero at the College of Pharmacy, Nova Southeastern University, 3200 South University Drive, Ft. Lauderdale, FL 33328 (jcaballe{at}nova.edu).


Purpose. The development and outcomes of an outpatient psychiatric pharmacy clinic serving a mostly indigent Hispanic population are described.

Summary. Su Clinica Familiar (SCF) is a community health center in Texas’s Lower Rio Grande Valley that sees over 30,000 patients a year, 20% of whom have a psychiatric disorder. In 2005 SCF began collaborating with a psychiatric clinical pharmacist to provide free psychiatric services within the health center. SCF patients with mental health complications were referred to the clinic by their primary care provider. Consultation notes were reviewed by the medical director, and treatment, if approved, was begun the same day. During the period from April 2005 to June 2006, 96 (77%) of 125 patients referred to the psychiatric pharmacy clinic actually attended it. Fifty-three (72%) of the 74 patients who were asked to return for follow-up care returned. Over 90% of the pharmacist’s clinical recommendations were accepted. Most referrals were for depression, anxiety, and cognitive impairment; other referrals were for insomnia, medication education, and smoking cessation. The medications most frequently prescribed were sertraline and donepezil. Cost savings were estimated at $22,380.

Conclusion. A psychiatric pharmacy clinic in an underserved region appeared to benefit patients’ mental health and save money.

Index terms: Ambulatory care; Clinical pharmacists; Clinical pharmacy; Economics; Mental disorders; Pharmaceutical services; Sociology

 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Society of Health-System Pharmacists.